These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17658412)

  • 1. Quality control in clinical flow cytometry.
    Oldaker TA
    Clin Lab Med; 2007 Sep; 27(3):671-85, viii. PubMed ID: 17658412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality control in flow cytometry for diagnostic pathology: II. A conspectus of reference ranges for lymphocyte immunophenotyping.
    McCoy JP; Overton WR
    Cytometry; 1994 Sep; 18(3):129-39. PubMed ID: 7813333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter study of reference stabilized human blood for lymphocyte immunophenotyping quality control in flow cytometry. GEIL.
    Baudouin F; Sarda MN; Goguel A; Béné MC
    Cytometry; 1999 Jun; 38(3):127-32. PubMed ID: 10397332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standardization in flow cytometry].
    Tatsumi N; Kitahashi S; Kubota H; Tsuda I; Yasui Y; Tanaka K; Kondo H
    Rinsho Byori; 1993 Sep; 41(9):982-9. PubMed ID: 8254976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric lymphocyte subset enumeration: 10 years of external quality assessment in the Benelux countries.
    Levering WH; van Wieringen WN; Kraan J; van Beers WA; Sintnicolaas K; van Rhenen DJ; Gratama JW
    Cytometry B Clin Cytom; 2008 Mar; 74(2):79-90. PubMed ID: 17849485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.
    Wood BL; Arroz M; Barnett D; DiGiuseppe J; Greig B; Kussick SJ; Oldaker T; Shenkin M; Stone E; Wallace P
    Cytometry B Clin Cytom; 2007; 72 Suppl 1():S14-22. PubMed ID: 17803189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of standardization on clinical cell analysis by flow cytometry.
    Keeney M; Barnett D; Gratama JW
    J Biol Regul Homeost Agents; 2004; 18(3-4):305-12. PubMed ID: 15786697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues for quality assurance in clinical flow cytometry.
    McCarthy RC; Fetterhoff TJ
    Arch Pathol Lab Med; 1989 Jun; 113(6):658-66. PubMed ID: 2658909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of flow cytometry in hematology and immunology.
    McCurley TL; Larson R
    Clin Lab Sci; 1996; 9(6):358-62. PubMed ID: 10165118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality Control of Immunophenotyping.
    Greig B
    Methods Mol Biol; 2019; 2032():227-279. PubMed ID: 31522423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies.
    Bromberg JE; Breems DA; Kraan J; Bikker G; van der Holt B; Smitt PS; van den Bent MJ; van't Veer M; Gratama JW
    Neurology; 2007 May; 68(20):1674-9. PubMed ID: 17502548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative identification of blood cell markers in human hematopoietic malignancies with diagnostic and prognostic significance.
    Kusenda J
    Neoplasma; 2008; 55(5):381-6. PubMed ID: 18665747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control in immunophenotyping: U.S. efforts to establish common methodology and their impact. American Society for Histocompatibility and Immunogenetics.
    Nicholson JK
    Eur J Histochem; 1994; 38 Suppl 1():7-12. PubMed ID: 8547714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group Experience.
    Solly F; Angelot-Delettre F; Ticchioni M; Geneviève F; Rambaud H; Baseggio L; Plesa A; Debliquis A; Garnache-Ottou F; Roggy A; Campos L; Aanei C; Rosenthal-Allieri A; Georget MT; Lachot S; Jacob MC; Robillard N; Wuilleme S; Andre-Kerneis E; Cornet E; Salaun V; Bennami H; Lhoumeau AC; Arnoulet C; Jacqmin H; Neyman N; Latger-Cannard V; Massin F; Lainey E; Le Garff-Tavernier M; Costopoulos M; Roussel M; Mayeur-Rousse C; Eischen A; Raggeneau V; Derrieux C; Maurer M; Asnafi V; Trinquand A; Brouzes C; Lhermitte L
    Cytometry A; 2019 Sep; 95(9):1008-1018. PubMed ID: 31364809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of quality assurance/quality control practices for CD4+ lymphocyte counting.
    Koepke JA
    Cytometry; 1996 Jun; 26(2):178-80. PubMed ID: 8817096
    [No Abstract]   [Full Text] [Related]  

  • 16. Flow cytometry and cytomorphology evaluation of hematologic malignancy in cerebrospinal fluids: comparison with retrospective clinical outcome.
    Cesana C; Klersy C; Scarpati B; Brando B; Faleri M; Bertani G; Gatti A; Volpato E; Barba C; Ferri U; Scampini L; Grillo G; Lando G; Nosari A; Morra E; Cairoli R
    Ann Hematol; 2011 Jul; 90(7):827-35. PubMed ID: 21212952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term stabilized blood samples as controls for flow cytometric HLA-B27 screening: a feasibility study.
    Levering WH; Wind H; Granger V; Sintnicolaas K; Hooijkaas H; Reilly JT; Gratama JW; Barnett D
    Cytometry B Clin Cytom; 2008 May; 74(3):169-81. PubMed ID: 18200592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality control in flow cytometry for diagnostic pathology. I. Cell surface phenotyping and general laboratory procedures.
    McCoy JP; Carey JL; Krause JR
    Am J Clin Pathol; 1990 Apr; 93(4 Suppl 1):S27-37. PubMed ID: 1690504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunophenotyping of haematologic malignancies].
    Koehorst SG; Evers H; van Buul T; de Vries F; Haanen C
    Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1861-5. PubMed ID: 15497779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications.
    Davis BH; Holden JT; Bene MC; Borowitz MJ; Braylan RC; Cornfield D; Gorczyca W; Lee R; Maiese R; Orfao A; Wells D; Wood BL; Stetler-Stevenson M
    Cytometry B Clin Cytom; 2007; 72 Suppl 1():S5-13. PubMed ID: 17803188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.